iOmx Therapeutics
Latest round
- Series B
Last raised
- Oct 2021
Total raised
- $120M
Investors
- 6
About iOmx Therapeutics
iOmx Therapeutics AG, founded in 2016 and headquartered in Munich, Germany, develops targeted cancer therapies.iOmx Therapeutics specializes in the development of targeted cancer immunotherapy treatments, focusing on the interplay between tumor and myeloid biology to create innovative therapeutic solutions for prevalent solid tumors. The company’s core offerings include a pipeline of biomarker-enabled drug programs aimed at addressing immune evasion mechanisms that allow tumors to proliferate. These therapies are designed to operate as single-agent treatments, potentially serving as backbone therapies within various cancer treatment regimens. iOmx targets a global market, implementing its solutions in regions where advanced cancer treatment protocols are established, including North America and Europe.iOmx Therapeutics generates revenue primarily through strategic partnerships and collaborations with pharmaceutical companies and research institutions focused on oncology. The transactional structure typically involves co-development agreements that may include milestone payments tied to clinical trial progress, as well as potential royalties on future product sales. These arrangements foster collaborative efforts to expedite the development and commercialization of iOmx's innovative therapies.00 mn, iOmx Therapeutics AG plans to advance its lead program IMT-07, a SIK3 kinase inhibitor aimed at treating solid tumors, and to develop IMT-18, a first-in-class monoclonal antibody targeting IGSF11 for PD-1/PD-L1-resistant tumors.
Who invested in iOmx Therapeutics
6 investors across 2 rounds
See all investors in iOmx Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about iOmx Therapeutics
Who invested in iOmx Therapeutics?
iOmx Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iOmx Therapeutics raised?
iOmx Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did iOmx Therapeutics last raise money?
iOmx Therapeutics's most recent round on record is a Series B, in Oct 2021.
What does iOmx Therapeutics do?
iOmx Therapeutics AG, founded in 2016 and headquartered in Munich, Germany, develops targeted cancer therapies.
Where is iOmx Therapeutics headquartered?
iOmx Therapeutics is headquartered in Munich, Germany.
Which VCs invest in companies like iOmx Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at iOmx Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like iOmx Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.